Comparison of helicobacter pylori eradication rate with quadriple therapy containing gemifloxacin versus clarithromycin in patients with h.pylori infectio
Phase 2
- Conditions
- Helicobacter pylori infection infection.Helicobacter pylori [H.pylori] as the cause of diseases classified to other chapters
- Registration Number
- IRCT2012102011054N2
- Lead Sponsor
- Vice chancellor for research,Tehran University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 140
Inclusion Criteria
Inclusion criteria : Age older than 18 years
Exclusion criteria: previous history of any treatment of h.pylori infection ? severe underlying diseases (renal failure, cirrhosis, congestive heart failure - cardiac, gastric surgery, any type of cancer) ?sensitivity to drugs which is used in study? taking any antibiotics by patients in 4 weeks before the study
Exclusion Criteria
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Helicobacterpylori infecetion. Timepoint: 8 weeks following end of treatment. Method of measurement: UBT.
- Secondary Outcome Measures
Name Time Method